Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
In brief
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
This is a summary provided by TechCrunch. Read the complete story on the publisher’s website.
Continue reading at TechCrunch ↗


